Per Kilogram Versus Nitrogen Balance Methods for Daily Protein Requirement in Cancer Patients
Comparison of Per Kilogram and Nitrogen Balance Calculations for the Prediction of Daily Protein Requirement in Cancer Patients: A Prospective Randomized Controlled Study
1 other identifier
interventional
103
1 country
1
Brief Summary
The goal of this study is to compare the effects of two dietary protein supplementation methods (per kg \[PK\] vs nitrogen balance equation \[NBE\]) on nutritional status, muscle strength, lean body mass, physical performance, and dietary compliance in cancer patients. The main questions it aims to answer are: Does the PK method improve muscle strength and lean body mass more effectively than the NBE method? Which method better supports nutritional status and physical performance in cancer patients? Are there differences in dietary compliance between the two methods? Researchers will compare the PK method (1.2-1.5 g/kg/day protein) to the NBE method (protein requirements based on nitrogen balance) to evaluate their impact on these outcomes. Participants will: Follow a personalized diet plan based on either the PK or NBE method Attend follow-up visits at weeks 4 and 8 for assessments of BMI, muscle mass, muscle strength, gait speed, serum albumin, and CRP Engage in moderate aerobic exercise (brisk walking) for at least 30 minutes a day, 5 days a week
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2020
CompletedFirst Submitted
Initial submission to the registry
February 4, 2025
CompletedFirst Posted
Study publicly available on registry
February 13, 2025
CompletedFebruary 13, 2025
February 1, 2025
5 months
February 4, 2025
February 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Muscle Strength Based on Different Protein Calculation Methods
Change in muscle strength from baseline to week 8, measured by a handheld dynamometer.
Baseline and 8 weeks
Change in Lean Body Mass Based on Different Protein Calculation Methods
Change in lean body mass from baseline to week 8, assessed via bioelectrical impedance analysis (BIA).
Baseline and 8 weeks
Change in Nutritional Status Based on Different Protein Calculation Methods
Improvement in nutritional status, evaluated using NRS-2002 scores from baseline to week 8.
Baseline and 8 weeks
Study Arms (2)
Per kg (PK)
ACTIVE COMPARATORDaily protein requirement was determined by PK in the first group and by NBE in the second group. Patients in the PK group received 1.2-1.5 g/kg/day of protein.
Nitrogen Balance Equation (NBE)
ACTIVE COMPARATORPatients in the NBE group were asked to record their food consumption and to collect a 24-hour urine sample on the same day for nitrogen balance calculation. Nitrogen balance was calculated by subtracting the amount of nitrogen excreted daily (urinary urea/2.14 + 3 g excreted in faeces) from the amount of nitrogen intake (24-h protein consumption \[g\]/6.25). The predicted daily protein requirement in the NBE group was calculated with daily nitrogen loss x 6.25 (g protein).
Interventions
Oral enteral nutrition products were added to the diet if the daily calorie and/or protein requirements could not be met by the diet. All of the patients underwent follow-up visits (4th and 8th weeks) after the initial assessment on admission. Each visit (0, 4th and 8th weeks) included screening of the nutritional status and food consumption, and measurements of body mass index (BMI), muscle mass, muscle strength, gait speed, serum albumin and serum C-reactive protein (CRP). Anthropometric measurements, muscle strength, physical performance, and the physical exercise plan were assessed.
Eligibility Criteria
You may qualify if:
- Cancer patients aged over 18 years
- Patients admitted to the outpatient clinics of Istanbul University, Institute of Oncology, between September 2019 and January 2020
You may not qualify if:
- Patients aged below 18 years
- Patients unable to feed orally (such as those with dementia, impaired consciousness, dysphagia, etc.)
- Dialysis patients
- Patients with psychiatric and/or eating disorders
- Patients receiving home parenteral nutrition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University
Istanbul, Fatih, 34093, Turkey (Türkiye)
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Bulent Saka, Professor
Istanbul University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass. Prof.
Study Record Dates
First Submitted
February 4, 2025
First Posted
February 13, 2025
Study Start
September 1, 2019
Primary Completion
January 30, 2020
Study Completion
March 30, 2020
Last Updated
February 13, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
all IPD that underlie results in a publication